Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alicia Tosoni

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
Anticancer Research|August 21, 2003
Breast cancer risk in symptomatic women spontaneously undergoing clinical breast examinationFranco Lumachi, Mario Ermani, Stefano M Basso, et al.
Frontiers in Oncology|March 21, 2022
Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic ChanceVincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
Drugs|April 9, 2022
Pharmacotherapeutic Treatment of Glioblastoma: Where Are We to Date?Lidia Gatto, Vincenzo Di Nunno, Enrico Franceschi, et al.
CNS Oncology|June 14, 2024
Novel insights toward diagnosis and treatment of glioneuronal and neuronal tumors in young adultsVincenzo Di Nunno, Marta Aprile, Lidia Gatto, et al.
Cancers|February 25, 2023
Tumor Microenvironment in Gliomas: A Treatment Hurdle or an Opportunity to Grab?Vincenzo Di Nunno, Marta Aprile, Lidia Gatto, et al.
Cancers|October 14, 2022
Diagnostic and Therapeutic Strategy in Anaplastic (Malignant) Meningioma, CNS WHO Grade 3Vincenzo Di Nunno, Caterina Giannini, Sofia Asioli, et al.
Frontiers in Oncology|July 3, 2023
CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gapLidia Gatto, Ilaria Ricciotti, Alicia Tosoni, et al.
Frontiers in Oncology|November 1, 2023
Olfactory neuroblastoma: diagnosis, management, and current treatment optionsAlicia Tosoni, Vincenzo Di Nunno, Lidia Gatto, et al.
Neuro-Oncology|April 11, 2008
Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncologyAlba A Brandes, Alicia Tosoni, Federica Spagnolli, et al.
Molecular Diagnosis & Therapy|June 7, 2021
IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma TreatmentLidia Gatto, Enrico Franceschi, Alicia Tosoni, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
Anticancer Research|August 21, 2003
Breast cancer risk in symptomatic women spontaneously undergoing clinical breast examinationFranco Lumachi, Mario Ermani, Stefano M Basso, et al.
Frontiers in Oncology|March 21, 2022
Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic ChanceVincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
Drugs|April 9, 2022
Pharmacotherapeutic Treatment of Glioblastoma: Where Are We to Date?Lidia Gatto, Vincenzo Di Nunno, Enrico Franceschi, et al.
CNS Oncology|June 14, 2024
Novel insights toward diagnosis and treatment of glioneuronal and neuronal tumors in young adultsVincenzo Di Nunno, Marta Aprile, Lidia Gatto, et al.
Cancers|February 25, 2023
Tumor Microenvironment in Gliomas: A Treatment Hurdle or an Opportunity to Grab?Vincenzo Di Nunno, Marta Aprile, Lidia Gatto, et al.
Cancers|October 14, 2022
Diagnostic and Therapeutic Strategy in Anaplastic (Malignant) Meningioma, CNS WHO Grade 3Vincenzo Di Nunno, Caterina Giannini, Sofia Asioli, et al.
Frontiers in Oncology|July 3, 2023
CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gapLidia Gatto, Ilaria Ricciotti, Alicia Tosoni, et al.
Frontiers in Oncology|November 1, 2023
Olfactory neuroblastoma: diagnosis, management, and current treatment optionsAlicia Tosoni, Vincenzo Di Nunno, Lidia Gatto, et al.
Neuro-Oncology|April 11, 2008
Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncologyAlba A Brandes, Alicia Tosoni, Federica Spagnolli, et al.
Molecular Diagnosis & Therapy|June 7, 2021
IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma TreatmentLidia Gatto, Enrico Franceschi, Alicia Tosoni, et al.
Pageof 11